US Pre-Market SEC Filings Roundup — July 16, 2026

15-07-2026

Chief Executive Officer Congleton Jon sold 10,700 Common Stock at $27.24 (~$291K). Congleton Jon holds 603,621 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · Chief Executive Officer Congleton Jon sold 10,700 Common Stock at $27.24 (~$291K)

15-07-2026

Director Hess Michael Bernard was awarded 2,000,000 Common Shares. Hess Michael Bernard holds 3,500,000 shares after the transaction.

• · Director Hess Michael Bernard was awarded 2,000,000 Common Shares
• · Director Hess Michael Bernard was awarded 1,000,000 Stock Option (right to buy)

15-07-2026

Chief Product Officer Kandal Philipp Wolfgang Josef sold 30,000 Class A Ordinary Shares at $3.83 (~$115K). Kandal Philipp Wolfgang Josef holds 4,018,735 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · Chief Product Officer Kandal Philipp Wolfgang Josef sold 20,000 Class A Ordinary Shares at $4.00 (~$80K)
• · Chief Product Officer Kandal Philipp Wolfgang Josef sold 30,000 Class A Ordinary Shares at $3.83 (~$115K)

15-07-2026

Chief Executive Officer Seidman Becker Caryn sold 89,592 Class A Common Stock at $53.31 (~$4.78M). Seidman Becker Caryn holds 51,770 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · Chief Executive Officer Seidman Becker Caryn sold 89,592 Class A Common Stock at $53.31 (~$4.78M)
• · Chief Executive Officer Seidman Becker Caryn sold 10,425 Class A Common Stock at $54.28 (~$566K)

15-07-2026

Chief Operating Officer O'Neill Jason Michael had withheld for taxes 30,782 Class A Ordinary Shares without par value at $3.68 (~$113K). O'Neill Jason Michael holds 527,691 shares after the transaction.

• · Chief Operating Officer O'Neill Jason Michael exercised/converted 103,734 Class A Ordinary Shares without par value
• · Chief Operating Officer O'Neill Jason Michael had withheld for taxes 30,782 Class A Ordinary Shares without par value at $3.68 (~$113K)
• · Chief Operating Officer O'Neill Jason Michael exercised/converted 103,734 Performance Share Units

15-07-2026

10% owner THRIVENT FINANCIAL FOR LUTHERANS sold 119,000 Class A Common Stock at $3.27 (~$389K). THRIVENT FINANCIAL FOR LUTHERANS holds 4,270,000 shares after the transaction.

• · 10% owner THRIVENT FINANCIAL FOR LUTHERANS sold 119,000 Class A Common Stock at $3.27 (~$389K)
• · 10% owner THRIVENT FINANCIAL FOR LUTHERANS sold 62,000 Class A Common Stock at $3.48 (~$216K)
• · 10% owner THRIVENT FINANCIAL FOR LUTHERANS sold 9,000 Class A Common Stock at $3.40 (~$30.6K)

15-07-2026

Director Sheena Jonathan sold 800 Common Stock at $264.29 (~$211K). 6 transactions reported in total. Sheena Jonathan holds 246,202 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · Director Sheena Jonathan sold 500 Common Stock at $262.72 (~$131K)
• · Director Sheena Jonathan sold 800 Common Stock at $264.29 (~$211K)
• · Director Sheena Jonathan sold 400 Common Stock at $265.15 (~$106K)
• · Director Sheena Jonathan sold 500 Common Stock at $266.75 (~$133K)
• · Director Sheena Jonathan sold 450 Common Stock at $267.72 (~$120K)
• · Director Sheena Jonathan sold 500 Common Stock at $268.39 (~$134K)

15-07-2026

President and CMO Chen Richard sold 100,000 Common Stock at $15.15 (~$1.52M). Chen Richard holds 173,880 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · President and CMO Chen Richard exercised/converted 100,000 Common Stock at $2.44 (~$244K)
• · President and CMO Chen Richard sold 100,000 Common Stock at $15.15 (~$1.52M)
• · President and CMO Chen Richard exercised/converted 100,000 Stock Option (right to buy)

15-07-2026

Director CAUTREELS WERNER was awarded 14,150 Stock Option (right to buy).

• · Director CAUTREELS WERNER was awarded 14,150 Stock Option (right to buy)

14-07-2026

XOMA Royalty Corp (XOMAP) filed a Form 25-NSE with the SEC on July 14, 2026, notifying the delisting of its Common Stock from the Nasdaq Stock Market. The delisting is pursuant to 17 CFR 240.12d2-2(a)(3), which typically applies to securities that are no longer traded on the exchange. No financial data, reasons for delisting, or future plans were disclosed in the filing.

• · Effective delisting date: July 14, 2026
• · Filing submitted by Nasdaq Stock Market LLC as the filer
• · Delisting rule: 17 CFR 240.12d2-2(a)(3)

16-07-2026

AJU IB Investment Co., Ltd. filed its quarterly Form 13F-HR with the SEC for the period ending June 30, 2026, disclosing its institutional holdings. The filing reports no reportable holdings for the quarter, with zero entries in the information table.

• · The filing was submitted on July 16, 2026, for the quarter ending June 30, 2026.
• · The filer is a South Korea-based investment company (CIK 0001710065).
• · The information table contains zero entries, indicating no reportable equity holdings as of the reporting date.

16-07-2026

Azul S.A. filed Form 25 with the SEC on July 16, 2026, to voluntarily withdraw its American Depositary Shares (ADSs) and common shares from listing and registration on NYSE American LLC. The delisting is a result of the company transferring its listing to the New York Stock Exchange (NYSE), which became effective on July 9, 2026, with the first day of trading on NYSE under the symbol 'AZUL'.

• · The delisting is voluntary and not due to any regulatory action or non-compliance.
• · The transfer to NYSE was effective on July 9, 2026, with first trading on that date.
• · Each ADS represents two common shares, no par value.
• · The company's principal executive offices are in Barueri, São Paulo, Brazil.

16-07-2026

BW LPG Ltd reported a Q2 2026 gross trading loss of USD 19 million for its Product Services segment, driven by a USD 146 million negative unrealized mark-to-market change that offset a USD 127 million realized trading gain. After expenses and taxes, the net result was a loss of USD 31 million. While the realized gain was strong, the overall segment performance was negative due to adverse market volatility and narrowing US/Asia LPG arbitrage.

• · The Q2 2026 trading result will be included in BW LPG's full Q2 2026 results, scheduled for release on 28 August 2026.
• · The increase in VAR to USD 17 million was driven by a surge in market volatility across core product exposures.
• · The company ended Q1 with a record high valuation of its forward trading portfolio, making a negative mark-to-market adjustment expected as the US/Asia LPG arbitrage narrowed.
• · BW LPG's fleet consists of about 50 VLGCs, with over 20 vessels powered by LPG dual-fuel propulsion technology.

16-07-2026

HDFC Bank Limited filed a Form 6-K with the SEC on July 16, 2026, reporting that it received approval from the Reserve Bank of India (RBI) for the appointment of Mr. Rajiv Kumar as Part-time Chairman of the Bank. This is a routine regulatory disclosure regarding a board-level appointment, with no financial figures or performance data included.

• · The appointment approval is from the Reserve Bank of India (RBI).
• · Mr. Rajiv Kumar will serve as Part-time Chairman.
• · The filing was signed on July 15, 2026.

16-07-2026

Senti Biosciences filed an S-3 shelf registration statement to register the resale of shares underlying $10.0M in Senior Secured Convertible Notes issued in a May 2026 private placement to Celadon Partners SPV 24. The company also disclosed a merger agreement with a Celadon affiliate that could trigger an additional $6.0M in Note purchases and a potential $60.0M contingent value right tied to SENTI-202 milestones. While the filing provides liquidity and a path to a potential merger, it also highlights significant dilution risk: the Selling Securityholder could own 54.6% to 77.5% of outstanding common stock depending on the extent of Note conversion and additional issuances.

• · The registration statement covers only the resale of shares underlying the Initial Notes; the company will not receive any proceeds from the resale.
• · The Merger Agreement was executed on July 14, 2026, more than 30 days after the Initial Notes closing.
• · The Notes have an initial exchange price of $0.6261 per share and are also convertible into common stock of Senti Holdings, Inc.
• · Issuance Approval (stockholder vote to exceed the 19.99% Exchange Cap) must be obtained by August 31, 2026.
• · The company has the right to force exchange of all outstanding Notes for common stock if the Merger closes.
• · The contingent value right may pay up to $60.0M in cash upon achievement of regulatory and sales milestones for SENTI-202.

16-07-2026

KB Financial Group Inc. completed a share buyback program, acquiring 3,581,623 common shares (1.01% of total issued shares) for a total of KRW 599,999,968,200 at an average price of KRW 167,522 per share. The acquisition period ran from April 24, 2026 to July 14, 2026, with final settlement on July 16, 2026.

• · Average acquisition price per share: KRW 167,522
• · No other shares (e.g., preferred) were acquired
• · The buyback program's final settlement date is July 16, 2026

16-07-2026

Stephens Group, LLC and related entities filed a Schedule 13G/A disclosing aggregate beneficial ownership of 9,252,632 shares of Westrock Coffee Co common stock, representing 9.0% of the class as of June 30, 2026. The filing includes shares issuable upon conversion of Series A Preferred Stock and a Convertible Senior Note held by SG-Coffee, LLC. The filing is a routine beneficial ownership update with no change in control intent.

• · The filing is an amendment (13G/A) to a previous Schedule 13G, filed under Rule 13d-1(c).
• · The Stephens Group, LLC is the sole manager of SG-Coffee, LLC and has voting and dispositive power over SG-Coffee's shares.
• · Stephens Group, LLC is beneficially owned by W.R. Stephens, Jr. and Elizabeth Stephens Campbell.
• · The filing certifies the securities were not acquired with the purpose of changing or influencing control of the issuer.

16-07-2026

AITX announced that its subsidiary, RAD, received a five-vehicle ROAMEO order from a global mining and natural resources company. The order was disclosed via a press release on July 16, 2026, and filed as an 8-K with the SEC. No financial terms or prior period comparisons were provided, so the material impact cannot be assessed.

• · The order is from a global mining and natural resources company (customer name not disclosed).
• · The press release is attached as Exhibit 99.1 to the 8-K filing.
• · The filing is furnished under Item 8.01 and is not deemed 'filed' for SEC liability purposes.

16-07-2026

IRIDEX Corporation held its 2026 Annual Meeting on July 10, 2026, where all five director nominees were elected despite a 'stealth proxy campaign' that the Board believes involved at least one director violating fiduciary duties and federal securities laws. The Board has launched an investigation and plans to engage with stockholders to address governance concerns. The company also disclosed its recent capital restructuring, including the issuance of Series B Preferred Stock and PIK notes to Novel Inspiration International Co., Ltd.

• · The meeting was initially convened on June 12, 2026 and adjourned to July 10, 2026 for investigation into unusual vote tallies.
• · Director Beverly A. Huss received only 5,739,133 votes for (43.6% of votes cast) and 7,436,354 withheld; Scott Shuda received 5,656,948 for (42.9%) and 7,518,539 withheld.
• · The Board believes a stealth proxy campaign involved at least one director and likely violated SEC proxy rules and Delaware fiduciary duties.
• · The company uses a plurality voting standard, so all nominees were elected despite significant withhold votes.
• · The company issued Series B Preferred Stock and PIK notes to Novel Inspiration International Co., Ltd in late 2024/early 2025 as part of a capital restructuring.
• · William Moore, a Novel nominee, previously served as director, chairman, and CEO and has a consulting relationship with a Novel affiliate.
• · The Board plans to meet with stockholders to discuss governance and fiduciary duties.

16-07-2026

UnitedHealth Group reported Q2 2026 revenues of $112.0B (+0.4% YoY) and earnings from operations of $8.0B (up from $5.2B in Q2 2025). Adjusted EPS rose to $6.38 from $5.17 in the prior year, and the company raised its full-year adjusted EPS guidance to $19.50–$20.00. However, UnitedHealthcare membership declined by 525,000 sequentially due to attrition in Employer & Individual (-145,000), Community & State (-380,000 from the Louisiana exit and Medicaid redeterminations), and Medicare Advantage (-965,000 since year-end 2025). Optum Rx adjusted scripts fell to 387M from 414M YoY, and Optum Health patients served declined by ~700,000.

• · Optum Insight completed the acquisition of Alegeus on July 2, 2026.
• · The company eliminated 33% of drug reauthorizations (11% of pharmacy prior approvals) for 270 chronic condition medications.
• · UnitedHealthcare's Gold Card program now excludes high-performing providers from routine prior approval, covering nearly 10% of total UHC prior approval volume.
• · The operating cost ratio increased to 12.7% in Q2 2026 from 12.3% in Q2 2025 due to targeted investments.
• · Days claims payable were 47.0 at Q2 2026, down from 48.6 at Q1 2026 but up from 44.5 at Q2 2025 (attributed to normal seasonality).
• · The company repurchased $4.0B of stock through mid-July 2026 on track for at least $5.0B for full year 2026.
• · A new Public Responsibility Committee was created for the Board, along with a new Lead Independent Director and committee chairs.
• · The independent HouseCalls program review showed an error rate nearly three times lower than CMS's most recent audits.
• · Full-year 2026 adjusted operating earnings guidance for UnitedHealth Group is >$25,215M.
• · The company committed to 100% pass-through of manufacturer drug rebate discounts to clients by January 1, 2028.

16-07-2026

Factorial Management Ltd filed its 13F-HR for the period ending June 30, 2026, disclosing holdings in three securities: Alibaba Group Holding Ltd notes, Trip.com Group Ltd notes, and HDFC Bank Ltd sponsored ADS. The report shows a concentrated portfolio with a total reported value of approximately $3.6 million, with no changes in share count from the prior period indicated.

• · Alibaba Group Holding Ltd note (CUSIP 01609WBG6): 1,000,000 principal amount, fair value $1,178,750
• · Trip.com Group Ltd note (CUSIP 89677QAB3): 1,000,000 principal amount, fair value $986,108
• · HDFC Bank Ltd sponsored ADS (CUSIP 40415F101): 56,260 shares, fair value $1,453,196
• · All holdings are reported as sole voting and dispositive power
• · Filing made by David Stanbridge, Chief Operating Officer, on July 14, 2026

16-07-2026

BlackRock, Inc. has crossed the 5% voting rights threshold in Caledonia Mining Corporation Plc, now holding a total of 6.18% of voting rights (5.00% via shares and 1.18% via financial instruments) as of July 14, 2026. This represents a slight increase from the previous notification of 6.22%, indicating a marginal decrease in BlackRock's overall position. The filing is a routine disclosure under UK regulations and does not reflect any material change in the company's operations or financial performance.

• · The threshold was crossed on July 14, 2026, and the issuer was notified on July 15, 2026.
• · BlackRock's direct voting rights (shares) increased from 4.92% to 5.00%, while indirect voting rights via financial instruments decreased from 1.30% to 1.18%.
• · The financial instruments include securities lending (0.78% or 151,911 voting rights) and CFDs (0.39% or 76,533 voting rights).
• · The issuer is a non-UK issuer (Caledonia Mining Corporation Plc is incorporated in Jersey).

16-07-2026

ASP Isotopes Inc. (ASPI) announced agreements to exchange approximately $109.2 million in principal amount of Quantum Leap Energy (QLE) convertible notes, plus accrued interest, for about 23.2 million shares of ASPI common stock (17.8% of outstanding shares). The exchange reduces QLE's outstanding convertible notes by roughly 50% from $219.8 million to $110.7 million, simplifying its capital structure as QLE pursues a standalone public listing. The transaction is expected to close on July 16, 2026, and is described as broadly economically neutral to both ASPI stockholders and QLE noteholders.

• · The exchange is intended to be broadly economically neutral to both ASPI stockholders and QLE noteholders.
• · QLE is a wholly-owned subsidiary of ASPI focused on nuclear fuel cycle technologies.
• · QLE has not applied its enrichment technologies to U-235 nor received regulatory approval for such testing, except under a services contract with Necsa.
• · The exchange supports ASPI's potential future distribution of QLE common equity to ASPI stockholders at a to-be-determined record date.

16-07-2026

International Stem Cell Corporation (ISCO) has entered into a Membership Interest Purchase Agreement to sell 100% of its subsidiary, Lifeline Cell Technology, LLC, to American Type Culture Collection, Inc. for a base purchase price of $25 million, subject to net working capital, cash, and indebtedness adjustments. The transaction includes a post-closing adjustment mechanism and is supported by a Support Agreement from requisite stockholders and a Transition Services Agreement.

• · The purchase price is subject to adjustments for estimated net working capital, closing date cash, and closing date indebtedness.
• · The closing will occur within two business days after satisfaction of closing conditions, with electronic exchange.
• · An escrow amount will be held for post-closing adjustments.
• · The seller must deliver evidence that the company has at least $250,000 cash at closing.
• · Concurrent support agreements and a transition services agreement were executed.

16-07-2026

Inotiv, Inc. received court confirmation of its prepackaged Chapter 11 plan of reorganization on July 14, 2026. Under the plan, all existing common shares (35,172,908 outstanding) will be canceled with no distribution to equity holders, resulting in a total loss for shareholders. The reorganized company will issue 5,100,000 new equity shares and warrants for 630,337 additional shares to prepetition lenders and noteholders, and expects to emerge as a private company.

• · The Chapter 11 cases are being jointly administered under the caption 'In re Inotiv, Inc., et al.' in the Southern District of Texas, Houston Division.
• · Nasdaq suspended trading of NOTV common shares on June 11, 2026; shares now trade OTC under symbol NOTVQ.
• · Nasdaq filed a Form 25 on July 10, 2026 to delist the shares; deregistration under Section 12(b) will be effective 90 days after filing.
• · The company expects to emerge from Chapter 11 as a private company.
• · The Confirmation Order was entered on July 14, 2026 (Docket No. 191).

16-07-2026

Dorian LPG Ltd. declared an irregular dividend of $1.00 per share, payable on August 12, 2026 to shareholders of record as of July 27, 2026. The company also completed the sale of the 2014-built VLGC Corsair for net proceeds of approximately $81.8 million. Future dividends remain subject to Board discretion based on various factors including financial condition and capital requirements.

• · The irregular dividend was declared by the Board of Directors on July 16, 2026.
• · Sale of the Corsair was previously announced and completed on July 8, 2026.
• · Proceeds from the vessel sale were approximately $81.8 million.

16-07-2026

News Corp filed an 8-K on July 16, 2026, to disclose routine ASX disclosures related to its ongoing $1 billion stock repurchase program. The filing reiterates the company's authorization to repurchase up to $1 billion in aggregate of its Class A and Class B common stock, but provides no new financial results or material changes. The disclosure is procedural and contains no specific repurchase activity or financial metrics for the period.

• · The repurchase program covers both Class A common stock (ticker NWSA) and Class B common stock (ticker NWS).
• · The ASX requires daily disclosure of repurchase transactions, which are attached as exhibits 99.1 and 99.2.
• · The filing includes forward-looking statements regarding the company's intent to repurchase shares from time to time.

16-07-2026

NextPlat Corp announced the strategic acquisition of an independent pharmacy near Pensacola, Florida for $1.5 million in cash, expected to close in Q4 2026. The target generated approximately $5.6 million in sales in 2025 with retail margins of about 19% and was profitable with a debt-free balance sheet. The acquisition expands NextPlat's PharmcoRx footprint into an underserved rural market and supports the launch of higher-margin contracted services, including 340B program offerings. However, the transaction is subject to final due diligence and customary closing conditions, and the company's ability to successfully integrate and expand as intended remains subject to known risks.

• · The pharmacy has served the local community for over 25 years.
• · The pharmacy maintained positive working capital and operated with a debt-free balance sheet.
• · NextPlat expects organic growth of approximately 20% in 2026, supported by increases in higher margin 340B and contracted services.
• · PharmcoRx has been operating for over 20 years in South and Central Florida.

16-07-2026

Global AI, Inc. entered into a Subscription Agreement with KSY Capital Investments, Inc. on July 9, 2026, issuing 250,000 shares of Class A common stock at $2.00 per share for aggregate proceeds of $500,000. The transaction closed the same day and was conducted as an unregistered sale under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D, with KSY representing accredited investor status. No prior-period comparisons are available, so no balanced performance assessment is possible.

• · The subscription agreement contains customary representations and warranties for a transaction of this type.
• · The shares were issued under exemption from registration in Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D.
• · KSY represented that it is an accredited investor within the meaning of Regulation D.
• · The shares may not be offered or sold in the United States absent registration or an applicable exemption.

16-07-2026

Stereotaxis, Inc. completed its acquisition of Robocath, a French medical robotics company, on July 7, 2026, acquiring 100% of its share capital and voting power. The filing incorporates supplemental risk factors related to the acquisition, including integration risks, retention of key personnel, and potential failure to realize anticipated benefits. No financial terms or performance metrics were disclosed in this filing.

• · The acquisition was completed on July 7, 2026, pursuant to a Share Sale Agreement dated April 14, 2026.
• · The filing incorporates supplemental risk factors from a Registration Statement on Form S-3 filed July 15, 2026.
• · The acquisition includes contingent payments tied to regulatory and commercial milestones.
• · The filing does not disclose the purchase price or any financial terms of the acquisition.

16-07-2026

Catalyst Pharmaceuticals, Inc. filed an 8-K on July 16, 2026, reporting the completion of an acquisition/disposition (Item 2.01) and related amendments to its certificate of incorporation (Items 3.01, 3.03, 5.01, 5.02, 5.03). The amended certificate authorizes only one class of common stock (1,000 shares, $0.001 par value) and includes standard provisions on director liability, indemnification, and exclusive forum (Delaware Chancery Court). No financial terms of the acquisition were disclosed in this filing.

• · The company is now authorized to issue only one class of stock (common stock), with 1,000 shares authorized at $0.001 par value.
• · The amended certificate includes exclusive forum provisions requiring derivative actions and fiduciary duty claims to be brought in the Delaware Court of Chancery.
• · Director liability is eliminated to the fullest extent permitted by Delaware law, and the company must indemnify directors and officers to the fullest extent.

16-07-2026

AIxCrypto Holdings, Inc. filed a 10-K/A for fiscal year 2025, disclosing executive compensation and performance metrics. The PEO's compensation actually paid remained flat at $524,542 in 2025, while the company's net loss widened to $(16.9) million from $(6.34) million in 2024. Total shareholder return (TSR) improved to $0.16 per $100 investment from a negative $(5.2) in 2024, but remains well below the 2023 level of $1.83.

• · The company's net loss widened from $(6.34) million in 2024 to $(16.9) million in 2025, a 166.6% increase.
• · Average non-PEO NEO compensation actually paid dropped sharply from $46,153 in 2024 to $37,500 in 2025, an 18.8% decline.
• · TSR improved from a negative $(5.2) in 2024 to $0.16 in 2025, but remains far below the $1.83 level in 2023.
• · PEO compensation actually paid in 2025 ($524,542) was essentially flat compared to 2024 ($504,183), but down 14.4% from 2023 ($612,865).

16-07-2026

Goldenstone Acquisition Ltd. (GDSTW) filed its Form 10-K for the fiscal year ended March 31, 2026, reporting a net loss of $414,679 compared to net income of $109,366 in the prior year, a deterioration largely due to lower interest income from the Trust Account and the absence of a franchise tax credit. The company's cash and investments held in Trust Account fell sharply from $18.7M to $5.9M as it redeemed significant public shares, and total liabilities more than doubled to $13.6M from $6.6M, driven by payables due to redeeming stockholders and increased related-party loans. While the company reduced operating costs slightly, the overall financial condition weakened with a larger accumulated deficit and negative working capital.

• · Working capital and extension loans from related party increased 32.4% to $3.94M as of March 31, 2026, from $2.98M a year earlier.
• · Accumulated deficit widened to ($7.94M) from ($6.52M) in the prior year.
• · Net cash used in operating activities improved to ($248,866) from ($1,493,543), a reduction of 83.3%.
• · Excise tax payable attributable to redemptions decreased to $195,713 from $380,443.
• · Total stockholders' deficit grew to ($7.94M) from ($6.52M).
• · The company had $5,618 cash on hand at March 31, 2026 versus $14,692 a year earlier.
• · Basic weighted average shares subject to redemption fell by 71.2% to 676,304 from 2,349,413.
• · Income before income taxes swung from income of $396,609 to a loss of ($337,582).

16-07-2026

Awareness Group, Inc. (TAAG) reported a dramatic turnaround for the nine months ended June 30, 2026, with net income attributable to TAAG of $614,925 compared to a net loss of ($852,108) in the prior-year period, driven by a surge in revenue to $5,337,090 from $466,383. However, the company remains in a net equity deficit of ($229,639) and total liabilities of $32.2M far exceed total assets of $31.9M, indicating continued financial strain. The results include the provisional consolidation of Prosper Energy, which contributed $20,550 in additional paid-in capital and $599,016 in non-controlling interests, but also required significant equity adjustments.

• · Solar project portfolio, net, decreased from $28.98M (Sep 30, 2025) to $27.81M (Jun 30, 2026).
• · Accounts receivable and contract assets surged to $3.60M from zero at Sep 30, 2025.
• · Notes receivable — current of $169,200 appeared as of Jun 30, 2026 (none previously).
• · Total current liabilities increased to $12.60M from $11.47M (Sep 30, 2025).
• · Non-controlling interests grew from $58,862 to $599,016, reflecting the Prosper Energy consolidation.
• · A Q3 reconciling equity adjustment of ($117,551) was booked to opening retained earnings, pending confirmation with the bookkeeper.
• · The Prosper Energy acquisition is provisional; the closing-date balance sheet and ASC 805 valuation are still pending.
• · No income tax provision was recorded in any period presented.
• · Cash provided by operating activities was $156,483 (9 months 2026) vs. cash used of ($123,491) in the prior period.
• · Cash used in financing activities was ($40,719) (9 months 2026) vs. cash provided of $272,587 in the prior period.

16-07-2026

COO Ye Gang sold 9,147 Class A ordinary shares at $109.67 (~$1M). 10 transactions reported in total. Ye Gang holds 360,000 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · COO Ye Gang sold 7,956 Class A ordinary shares at $109.00 (~$867K)
• · COO Ye Gang sold 9,147 Class A ordinary shares at $109.67 (~$1M)
• · COO Ye Gang sold 2,849 Class A ordinary shares at $110.73 (~$315K)
• · COO Ye Gang sold 48 Class A ordinary shares at $111.43 (~$5.35K)
• · COO Ye Gang sold 225 Class A ordinary shares at $109.07 (~$24.5K)
• · COO Ye Gang sold 4,252 Class A ordinary shares at $110.76 (~$471K)
• · COO Ye Gang sold 4,055 Class A ordinary shares at $111.60 (~$453K)
• · COO Ye Gang sold 4,721 Class A ordinary shares at $112.57 (~$531K)

16-07-2026

Chief Executive Officer Wang Haijun was awarded 418,250 Employee Stock Options (Right to buy).

• · Chief Executive Officer Wang Haijun was awarded 418,250 Employee Stock Options (Right to buy)
• · Chief Executive Officer Wang Haijun was awarded 250,950 Employee Stock Options (Right to buy)
• · Chief Executive Officer Wang Haijun was awarded 167,300 Employee Stock Options (Right to buy)

16-07-2026

Global Net Lease, Inc. furnished a press release on July 16, 2026 under Regulation FD. The filing does not disclose any financial results, operational metrics, or material events; it merely references the attached press release (Exhibit 99.1) without providing its content. No quantitative data or period-over-period comparisons are available.

• · The press release was issued on July 16, 2026 and is attached as Exhibit 99.1.
• · The filing is a Regulation FD disclosure and the information is furnished, not filed.
• · No financial statements or other exhibits beyond the press release were included.

16-07-2026

Aberdeen Group plc and its subsidiary abrdn Inc. filed an amended Schedule 13G with the SEC on July 16, 2026, disclosing beneficial ownership of 824,393 shares of Immunic, Inc. common stock, representing 6.05% of the outstanding shares. The filing is an administrative update to reflect a new CUSIP following a 1-for-10 reverse stock split effective April 27, 2026; the ownership percentage remained unchanged from the prior filing.

• · The filing is an amendment to Schedule 13G, not an initial filing.
• · The amendment updates the issuer's CUSIP following a 1-for-10 reverse stock split effective April 27, 2026.
• · The shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
• · abrdn Inc. is the direct beneficial owner on behalf of underlying clients; Aberdeen Group plc is the parent company.

16-07-2026

JIA Investment Alliance Pte. Ltd. (formerly GuoLine Advisory Pte Ltd) filed its 13F-HR for the quarter ended June 30, 2026, reporting a total of 23 equity holdings with an aggregate market value of approximately $1.074 billion. The portfolio is concentrated in large-cap technology and healthcare names, with top positions in Alphabet, Amazon, Apple, and Microsoft. The filing reflects a diversified, growth-oriented strategy with no options or convertible securities reported.

• · The filer changed its name from GuoLine Advisory Pte Ltd to JIA Investment Alliance Pte. Ltd. on February 21, 2023.
• · All 23 positions are held with sole voting and dispositive power; no shared or non-dispositive holdings.
• · Largest single position is Alphabet Inc. Class A at $132.3 million (370,200 shares).
• · Smallest reported position is Arthur J. Gallagher & Co. at $12.0 million (52,400 shares).
• · No options, warrants, or convertible securities are reported; all holdings are common stock or ADRs.

16-07-2026

Rentokil Initial plc disclosed that John Pettigrew, its Senior Independent Director, has been appointed as a non-executive director of SSE plc, effective December 1, 2026. This is a routine director declaration under UK Listing Rules and does not involve any financial results, acquisitions, or regulatory actions.

• · John Pettigrew's appointment to SSE plc board is effective from 1 December 2026.
• · Disclosure is made in accordance with UK Listing Rule 6.4.9.

16-07-2026

Orangekloud Technology Inc. filed Amendment No. 2 to its Form 6-K to correct typographical errors in Exhibit 99.1, which contains the company's 2025 Equity Incentive Plan (revised and updated on May 8, 2026). The amendment replaces the previously furnished exhibit in its entirety, while the rest of the original report remains unchanged. This is a routine administrative correction with no new financial or operational disclosures.

• · The original Form 6-K was filed on May 20, 2026, and amended by Amendment No. 1 on May 28, 2026.
• · The corrected Exhibit 99.1 replaces the version previously furnished with the original Form 6-K.
• · The company is a foreign private issuer with commission file number 001-42189.

16-07-2026

Chairman, CEO and President CASALE MARK sold 78,699 Common shares, par value $0.015 at $65.23 (~$5.13M). CASALE MARK holds 2,081,544 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · Chairman, CEO and President CASALE MARK sold 23,900 Common shares, par value $0.015 at $65.07 (~$1.56M)
• · Chairman, CEO and President CASALE MARK sold 78,699 Common shares, par value $0.015 at $65.23 (~$5.13M)

16-07-2026

Director Yang Donghao exercised/converted 9,072 Class A ordinary shares. Yang Donghao holds 18,144 shares after the transaction.

• · Director Yang Donghao exercised/converted 9,072 Class A ordinary shares
• · Director Yang Donghao exercised/converted 9,072 Restricted Share Units